Jo Jewell Announces Novartis Foundation and Novo Nordisk Collaboration
Jo Jewell, Director, Head of Social Responsibility Partnerships at Novo Nordisk, shared on LinkedIn:
”We’re excited to see the Novartis Foundation and Novo Nordisk join forces to tackle cardiometabolic risk in cities.
Our new collaboration will combine insights and proven approaches from the two leading urban health programmes CARDIO 4 Cities (Novartis Foundation and Cities for Better Health (Novo Nordisk).
Initially launching in two European capitals, the goal is to build scalable models using practical tools, real-time data and catalytic funding to scale prevention and strengthen health systems in many more cities.
By working together, our collaboration has the potential to create lasting impact on urban health and social inequities.
Learn more:
Stay updated with Hemostasis Today.
-
Jun 24, 2026, 17:36Paul Whiteley: Neurodevelopmental and Autism Risks in Fetal and Neonatal Alloimmune Thrombocytopenia
-
Jun 24, 2026, 17:22Kavitha Dev: A Low Platelet Count Isn’t Always Critical, But It Should Never Be Ignored
-
Jun 24, 2026, 17:04Recurrent Cervical Internal Carotid Vasospasm Linked to Autosomal Recessive PTGIS Defect – International Journal of Stroke
-
Jun 24, 2026, 16:49Gaurav Kharya: Bridging the Gap in Safe Blood Access for Patients Who Can’t Wait
-
Jun 24, 2026, 16:40William Wallace: Vitamin C and Collagen Work as One Biological System
-
Jun 24, 2026, 16:32Arlindo Nascimento de Lemos Junior: Thrombus Echogenicity as a Predictor of Post-Thrombotic Syndrome Severity After DVT
-
Jun 24, 2026, 16:09Jimi Olaghere: The Future of Sickle Cell Disease Research Starts With Collaboration
-
Jun 24, 2026, 16:03Von Willebrand Disease as a Common Yet Under-Recognised Bleeding Disorder – EHC
-
Jun 24, 2026, 15:57Maia Meier: Women with Bleeding Disorders Reach the Summit of Mont Blanc